Staging is the process of learning how much cancer is in your body and where it is. Tests like biopsy, angiogram, bone scan, ultrasound, PET scan, CT, and MRI may be done to help stage your cancer. Your providers need to know about your cancer and your health so that they can plan the best treatment for you.
There are a few kinds of liver cancer, named for the type of cell that the cancer starts in.
There are a few staging systems for liver cancer.
Cancer staging looks at the size of the tumor and where it is, and if it has spread to other organs. It has three parts:
Your healthcare provider will use the results of the tests you had to figure out your TNM result and combine these to get a stage from 0 (zero) to IV (four).
The AJCC system for staging for liver cancer is based on:
The staging system is very complex. Below is a summary of the staging. Talk to your provider about the stage of your cancer.
Stage IA (T1a, N0, M0): A single tumor 2 centimeters (cm) or smaller that hasn't grown into blood vessels (T1a). It has not spread to nearby lymph nodes (N0) or to distant sites (M0).
Stage IB (T1b, N0, M0): A single tumor larger than 2cm that hasn't grown into blood vessels (T1b). The cancer has not spread to nearby lymph nodes (N0) or to distant sites (M0).
Stage II (T2, N0, M0): Either a single tumor larger than 2 cm that has grown into blood vessels, OR more than one tumor but none are larger than 5 cm (T2). It has not spread to nearby lymph nodes (N0) or to distant sites (M0).
Stage IIIA (T3, N0, M0): More than one tumor, with at least one tumor larger than 5 cm (T3). It has not spread to nearby lymph nodes (N0) or to distant sites (M0).
Stage IIIB (T4, N0, M0): At least one tumor (any size) that has grown into a major branch of a large vein of the liver (the portal or hepatic vein) (T4). It has not spread to nearby lymph nodes (N0) or to distant sites (M0).
Stage IVA (Any T, N1, M0): A single tumor or many tumors of any size (Any T) that has spread to nearby lymph nodes (N1) but not distant sites (M0).
Stage IVB (Any T, Any N, M1): A single tumor or many tumors of any size (any T). It may have spread to nearby lymph nodes (any N). It has spread to distant organs such as the bones or lungs (M1).
Treatment for liver cancer depends on many things, like your cancer stage, age, overall health, and testing results.
Your treatment may include some or all the following:
The type of surgery that you have depends on where your tumor is, the stage, and your overall health. Surgery is often only used if the cancer has not spread outside of your liver (metastasized).
There are two main types of surgery used for liver cancer:
Talk with your provider about whether surgery will be a part of your treatment plan.
There are a few ways that liver cancer can be treated that only affect the cancer, called local treatments. These procedures can often be used if you are unable to have surgery. Some examples are:
Radiation therapy is the use of high-energy x-rays to kill cancer cells. Radiation is not often used to treat liver cancer because it can damage the healthy parts of the liver. It can be used when other treatment options have not worked. Radiation may also be used to treat areas in the body where the cancer has spread and is causing side effects such as bone pain.
The most common type of radiation used for liver cancer is called stereotactic radiation (SBRT). Many different angles are used to focus the radiation at one small point. These beams combine to deliver high doses of radiation to the specific area of the liver tumor. This helps lessen how much of the liver receives radiation.
Liver cancer may be treated with targeted therapies that focus on specific gene mutations or proteins in the tumor. Targeted therapies work by targeting something specific to a cancer cell, which helps kill cancer cells while affecting healthy cells less. Sometimes the “target” is found on a certain type of healthy cell and side effects can happen as a result.
Examples of targeted therapy medications used for liver cancer are sorafenib, lenvatinib, regorafenib, cabozantinib, bevacizumab, and ramucirumab.
Immunotherapy is the use of a person's own immune system to kill cancer cells.
Immunotherapy medications that may be used to treat this type of cancer are atezolizumab, durvalumab, pembrolizumab, nivolumab, ipilimumab, and tremelimumab.
Chemotherapy is the use of anti-cancer medications to kill cancer cells. Chemotherapy is mostly used when liver cancer has metastasized. It may also be used after surgery, to kill any cancer cells that may be left in the body. This is called adjuvant therapy. Most times, a combination of different medications are given together.
Chemotherapy medications that may be used to treat liver cancer are gemcitabine, oxaliplatin, cisplatin, doxorubicin (pegylated liposomal doxorubicin), 5-fluorouracil, capecitabine, and mitoxantrone.
You may be offered a clinical trial as part of your treatment plan. To find out more about current clinical trials, visit the OncoLink Clinical Trials Matching Service.
Your care team will make sure you are included in choosing your treatment plan. This can be overwhelming as you may be given a few options to choose from. It feels like an emergency, but you can take a few weeks to meet with different providers and think about your options and what is best for you. This is a personal decision. Friends and family can help you talk through the options and the pros and cons of each, but they cannot make the decision for you. You need to be comfortable with your decision – this will help you move on to the next steps. If you ever have any questions or concerns, be sure to call your team.
You can learn more about liver cancer at OncoLink.org.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania